Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Welch

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
Pediatric Blood & Cancer|January 11, 2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaM L Sulis, T M Blonquist, K E Stevenson, et al.
Hospital Pediatrics|January 19, 2024
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address DisparitiesKristine A Karvonen, Puja J Umaretiya, Victoria B Koch, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
British Journal of Haematology|August 14, 2024
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemiaQianqian Zhu, Ram Nambiar, Emily Schultz, et al.
Blood Advances|June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
Pediatric Blood & Cancer|January 11, 2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaM L Sulis, T M Blonquist, K E Stevenson, et al.
Hospital Pediatrics|January 19, 2024
Inequitable Poverty Exposures: A Subspecialty Opportunity to Address DisparitiesKristine A Karvonen, Puja J Umaretiya, Victoria B Koch, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Pediatric Blood & Cancer|November 2, 2017
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001Justine M Kahn, Peter D Cole, Traci M Blonquist, et al.
British Journal of Haematology|August 14, 2024
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemiaQianqian Zhu, Ram Nambiar, Emily Schultz, et al.
Blood Advances|June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Blood Advances|March 7, 2018
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemiaThai Hoa Tran, Marian H Harris, Jonathan V Nguyen, et al.
Pageof 5